Keap1 Antibodies

Santa Cruz Biotechnology features a diverse variety of Keap1 monoclonal antibodies for various research applications. Keap1 Antibodies are optimized for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Keap1, or Kelch-like ECH-associated protein 1, plays a crucial role in cellular defense mechanisms by regulating the Nrf2 pathway, which is essential for the antioxidant response. Keap1 is significant in protecting cells from oxidative stress and inflammation, making it a key player in various diseases, including cancer and neurodegenerative disorders. Understanding Keap1 function and interactions can provide insights into therapeutic strategies for these conditions. Researchers worldwide utilize Keap1 monoclonal antibodies to investigate cellular stress responses and potential therapeutic targets. Advanced research techniques incorporating Keap1 monoclonal antibodies have revealed new pathways in cellular protection mechanisms. The reliability and specificity of Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to understanding cellular defense mechanisms and disease treatments.